Kinkan Liniment
NDC 51027-0007
Product Information
Kinkan (ammonia, camphor (natural), menthol) is a OTC MONOGRAPH DRUG-approved product labeled by Kinkando Co., Ltd .. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a liniment for topical administration. This product entry covers the primary NDC 51027-0007 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 51027-0007?
What are the uses of this product?
What are Active Ingredients of this product?
- AMMONIA 1.1 g/50mL - A colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions. Note that the aqueous form of ammonia is referred to as AMMONIUM HYDROXIDE.
- CAMPHOR (NATURAL) 1.55 g/50mL
- MENTHOL 3 g/50mL - A monoterpene cyclohexanol produced from mint oils.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- AMMONIA (UNII: 5138Q19F1X)
- AMMONIA (UNII: 5138Q19F1X) (Active Moiety)
- CAMPHOR (NATURAL) (UNII: N20HL7Q941)
- CAMPHOR (NATURAL) (UNII: N20HL7Q941) (Active Moiety)
- MENTHOL (UNII: L7T10EIP3A)
- MENTHOL (UNII: L7T10EIP3A) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALCOHOL (UNII: 3K9958V90M)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2265634 - ammonia 2.3 % / camphor 3.1 % / menthol 6 % Topical Solution
- RxCUI: 2265634 - ammonia 23 MG/ML / camphor 31 MG/ML / menthol 60 MG/ML Topical Solution
* Please review the full disclaimer at the bottom of this page.